| Year |
|---|
| Current Assets |
| Cash & Short Term Investments |
| Cash And Cash Equivalents |
| Short Term Investments |
| Net Receivables |
| Inventory |
| Other Current Assets |
| Non-Current Assets |
| Property, Plant & Equipment |
| Goodwill And Intangible Assets |
| Goodwill |
| Intangible Assets |
| Long Term Investments |
| Tax Assets |
| Other Non-Current Assets |
| Other Assets |
| Total Assets |
| Current Liabilities |
| Accounts Payable |
| Short Term Debt |
| Tax Payables |
| Deferred Revenue |
| Other Current Liabilities |
| Total Current Liabilities |
| Total Non-Current Liabilities |
| Long-Term Debt |
| Deferred Revenue |
| Deferred Taxes Liabilities |
| Other Non Current liabilities |
| Total Liabilities |
| Other Liabilities |
| Stockholders Equity |
| Common Stock |
| Retained Earnings |
| Accumulated Other Comprehensive Income/Loss |
| Other Shareholders Equity |
| Total Liabilities and Stockholders Equity |
Advanced Enzyme Technologies Limited
ADVENZYMES.NS
NSE
276.45INR5.3 (0.33%)
ADVENZYMES.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 10.02B | 9.07B |
| Net Income | 1.33B | 1.06B |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -567.12M | -125.42M |
| Retained Earnings | 10.79B | 10.02B |
| Other Distributions | 205.02M | 824.38M |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 3.07B | 2.89B |
| Annual Depreciation | 352.42M | 350.29M |
| Capital Expenditure | -423.13M | -381.81M |
| Net PPE | 3.14B | 2.92B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 44.42M | 247.9M |
| Goodwill (Previous Year) | 3.21B | 2.96B |
| Goodwill | 3.25B | 3.21B |